Capecitabine

Capecitabine
Capecitabine tablets are indicated as a single agent for adjuvant treatment in patients with Dukes’ C colon cancer who have undergone complete resection of the primary tumor when treatment with fluoropyrimidine therapy alone is preferred. Capecitabine tablets are noninferior to 5-fluorouracil and leucovorin (5-FU/LV) for disease-free survival (DFS). Physicians should consider results of combination chemotherapy trials, which have shown improvement in DFS and OS, when prescribing single-agent capecitabine tablets in the adjuvant treatment of Dukes’ C colon cancer.
Products Information
RX PRODUCT | NDC# | STRENGTH | SIZE | PRODUCT CLASS | ADMINISTRATION | CASE SIZE |
---|---|---|---|---|---|---|
Capecitabine | 59923-722-12 | 500 mg | 120 | Antineoplastic | Oral | N.A |
Wholesaler | Capecitabine 500mg |
---|---|
AmerisourceBergen | 10235955 |
Cardinal | 5680699 |
McKesson | 1573468 |
Download Product Information